| 1 |
Isolation and characterization of the new SARS-CoV-2 variant in travellers from the United Kingdom to India: VUI-202012/01 of the B.1.1.7 lineage |
Published in Journal of Travel Medicine
Oxford University Press |
 |
| 2 |
Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2 |
Published in Journal of Travel Medicine
Oxford University Press |
|
| 3 |
Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travellers from South Africa and Tanzania to India |
Published in Travel Medicine & Infectious Diseases
Elsevier, Netherlands |
|
| 4 |
An epidemiological analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India |
Published in Viruses
MDPI, Switzerland |
|
| 5 |
Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees |
Published in Clinical Infectious Diseases |
|
| 6 |
Neutralization of VUI B.1.1.28 P2 variant with sera of COVID-19 recovered cases and recipients of Covaxin an inactivated COVID-19 vaccine |
Published in Journal of Travel Medicine |
|
| 7 |
Comparison of SARS-CoV-2 VOC 202012/01 (UK variant) and D614G variant transmission by different routes in Syrian hamsters |
Published in Vector Borne & Zoonotic Diseases
Mary Ann Liebert, Inc. Publishers, USA |
|
| 8 |
Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1 |
Accepted in Clinical Infectious Diseases
Oxford University Press |
|
| 9 |
Detection of SARS-CoV-2 variants in India from UK returnees |
Accepted in Infection
Springer, Germany |
|
| 10 |
SARS CoV-2 variant B.1.617.1 is highly pathogenic in hamsters than B.1 variant |
Under review in Clinical Infectious Diseases
Released on BioRxiv |
|
| 11 |
Comparison of the pathogenicity and virus shedding of SARS CoV-2 VOC 202012/01 and D614G variant in hamster model |
Under review in Scientific reports
Released on BioRxiv |
|
| 12 |
Isolation and characterization of SARS-CoV-2 VOC, 20H/501Y.V2, from UAE travellers |
Under review in Travel Medicine & Infectious Diseases
Released on BioRxiv |
|
| 13 |
Possible role of accessory proteins in the viral replication for the 20I/501Y.V1 (B.1.1.7) SARS-CoV-2 variant |
Published in Pathogens
MDPI, Switzerland |
|
| 14 |
Isolation of SARS-CoV-2 B.1.1.28.2 P2 variant and pathogenicity comparison with D614G variant in hamster model |
Published in Journal of Infection and Public Health |
|
| 15 |
Detection of SARS CoV-2 VUI-202102/03 variant (B.1.525) from India. |
Under review in Indian Journal of Medical Research |
|
| 16 |
Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin |
Published in Journal of Travel Medicine |
|
| 17 |
Neutralization of Delta variant with sera of Covishield™ vaccinees and COVID-19 recovered vaccinated individuals |
Published in Journal of Travel Medicine
Oxford University Press |
|
| 18 |
Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/COVAXIN |
Published in Journal of Travel Medicine
Oxford University Press |
|
| 19 |
Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India |
Published in Viruses
MDPI, Switzerland |
|
| 20 |
SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters |
Published in Viruses
MDPI, Switzerland |
|
| 21 |
Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta in individuals sera vaccinated with BBV152 |
Published in International Society of Travel Medicine |
|
| 22 |
Immunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 Covaxin |
Published in Journal of Travel Medicine
Oxford University Press |
|
| 23 |
Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021 |
Published in Journal of Infection |
|
| 24 |
Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and Delta variant in India, 2021: A case-control study |
Preprint |
|
| 25 |
ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 Infection |
Published in Viruses
MDPI, Switzerland |
|
| 26 |
An in vitro and in vivo approach for the isolation of Omicron variant from human clinical specimens |
Preprint bioRxiv |
|
| 27 |
Persistence of immunity and impact of a third (booster) dose of an inactivated SARS-CoV-2 vaccine, BBV152; a phase 2, double-blind, randomised controlled trial |
Preprint medRxiv |
|
| 28 |
Delta Variant SARS-CoV-2 infections in pediatric cases during the second wave in India |
Preprint medRxiv |
|
| 29 |
Pathogenicity of SARS-CoV-2 Omicron in Syrian hamsters and its neutralization with different Variants of Concern |
Preprint bioRxiv |
|
| 30 |
Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concerns |
Published in Journal of Infection |
|
| 31 |
Detection of Zika virus disease in Thiruvananthapuram, Kerala, India 2021 during the second wave of COVID-19 pandemic |
Published in Journal of Medical Virology |
|
| 32 |
Isolation and Genomic Characterization of SARS-CoV-2 Omicron Variant Obtained from Human Clinical Specimens |
Published in Viruses
MDPI, Switzerland |
|
| 33 |
A case with SARS-CoV-2 reinfection from India |
Published in Indian Journal of Medical Microbiology
Elsevier |
|
| 34 |
SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera |
Published in Journal of Infection
Elsevier |
|
| 35 |
Detection and isolation of SARS-CoV-2 Eta variant from the international travelers and local residents of India |
Accepted in Journal of Medical Virology |
|
| 36 |
Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters |
Published in Viruses
MDPI, Switzerland |
|
| 37 |
Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021 |
Published in Journal of Infection
Elsevier |
|
| 38 |
Development of a Reverse Transcription Loop - Mediated Isothermal Amplification [RT-LAMP] as a early rapid detection assay for Crimean Congo Hemorrhagic Fever virus |
Accepted in Science Direct |
|
| 39 |
Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern |
Published in eBioMedicine |
|
| 40 |
A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional |
Accepted in Journal of Infection
Elsevier |
|
| 41 |
Reduced neutralizing antibody response in naive Covishield vaccinees against Omicron emphasizes booster vaccination |
Accepted in Journal of Infection
Elsevier |
|
| 42 |
Isolation and characterization of SARS-CoV-2 Beta variant from UAE travelers |
Published in Journal of Infection and Public Health
Elsevier |
|
| 43 |
SARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model |
Accepted in Vector Borne & Zoonotic Diseases
Mary Ann Liebert, Inc. Publishers, USA |
|
| 44 |
Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model |
Preprint bioRxiv |
|
| 45 |
Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant |
Online Print Human Vaccines & Immunotherapeutics |
|
| 46 |
Vaccination saves lives: A real-time study of patients with chronic diseases and severe COVID-19 infection |
Accepted in QJM: An International Journal of Medicine |
|
